NASDAQ$HWKN

Hawkins Inc · Q4 2024 earnings

Q4 2024 earnings · · Investor relations

Briefing

Reported fourth quarter and fiscal year 2024 results.

Hawkins, Inc. reported a decrease in sales by 2% compared to the same quarter in the prior year, with Water Treatment segment sales growth of 21%. Record fourth quarter diluted earnings per share (EPS) of $0.66, which was 20% higher than the same period of the prior year.

  • Fourth quarter sales were $223.0 million, down 2% compared to the same quarter in the prior year, with Water Treatment segment sales growth of 21%.
  • Gross profit was $45.5 million, a 27% increase over the same quarter in the prior year, contributing to a 9% increase in operating income.
  • Record fourth quarter diluted earnings per share (EPS) was $0.66, which was 20% higher than the same period of the prior year.
  • Record fourth quarter operating cash flow of $41.9 million allowed the company to pay down $21 million in debt.

Headline financials

Total Revenue

$223M

Previous: $228M-2.2%
EPS (adj)

$0.66

Previous: $0.55+20.0%
Adjusted EBITDA

$31M

No prior period
Capital Expenditures

-$11.9M

Previous: $16M-174.3%
Net Income

$13.8M

Previous: $11.6M+19.2%
Operating Income

$20.1M

Previous: $18.5M+8.7%
Gross Profit

$45.5M

Previous: $35.7M+27.4%
Stock-Based Comp

$1.37M

Previous: $1.06M+29.5%

Revenue & EPS history

Hawkins · Revenue · Quarterly

$223M

Q4 2024-2.2%vs Q4 2023
Beat estimate in 7 of 13 quarters(54%)
ActualEstimate

Revenue by segment

Hawkins · $237M total across 3 segments · Q2 2024

  • Water Treatment
    $101M+16.7%
  • Industrial Solutions
    $98.5M-13.5%
  • Food & Health Sciences
    $37.1M-9.1%

Forward guidance

The company expects to see continued top and bottom-line growth, with top line approaching $1 billion in revenue and Water Treatment becoming the largest reporting segment. Cautiously optimistic about the Industrial segment, but believe economic and competitive pressures will continue to weigh on customers and impact demand. Expect the improved performance in Health and Nutrition to continue into fiscal 2025, and expect results to be higher than fiscal 2024. Strong operating cash flow will allow to fund future investments for growth while continuing to pay down debt during fiscal year 2025.

Tailwinds

  • Continued top and bottom-line growth expected.
  • Top line approaching $1 billion in revenue.
  • Water Treatment becoming the largest reporting segment.
  • Improved performance in Health and Nutrition expected to continue into fiscal 2025.
  • Strong operating cash flow to fund future investments and pay down debt.

Headwinds

  • Economic and competitive pressures will continue to weigh on Industrial segment customers.
  • Economic and competitive pressures will impact demand in Industrial segment.
  • Changes in regulation.
  • Changes in the labor markets.
  • Changes in competition and price pressures.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q4 2024

Historical avgQ4 2024

+0.7%

Avg return

Earnings day

+1.6%

Avg return

5 days after

+5.6%

Avg return

30 days after

56%

36 / 64 earnings

Positive

+17.6%

Q1 2025

Best reaction

-10.2%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026-3.2%-5.5%-2.1%
Q3 2026-9.1%-17.6%-3.0%
Q2 2026-5.0%-19.0%-18.0%
Q4 2025-0.7%+5.8%+13.5%
Q3 2025-8.4%-0.1%-9.6%
Q2 2025-8.8%-9.3%+14.8%
Q1 2025+17.6%+11.1%+22.8%
Q4 2024+9.4%+15.4%+13.1%
Q3 2024-10.2%-13.5%+1.7%
Q2 2024-5.1%+5.8%+9.0%
Q1 2024+7.1%+10.2%+35.9%
Q4 2023+12.3%+9.1%+15.4%
Q3 2023+9.8%+5.5%+8.1%
Q2 2023-2.3%-9.5%-9.6%
Q1 2023+3.9%+7.4%-1.7%
Q4 2022-7.5%-10.5%-7.2%
Q3 2022+9.4%+5.8%+23.9%
Q2 2022-7.1%-4.7%-11.6%
Q1 2022+14.9%+12.4%+22.3%
Q4 2021+4.0%+2.5%-0.3%
Q3 2021+9.7%+11.5%+25.1%
Q2 2021+3.8%-5.8%+2.6%
Q1 2021+2.1%+8.7%+7.5%
Q4 2020+9.3%+14.9%+11.0%
Q3 2020+0.7%+0.9%-6.7%
Q2 2020+4.0%+7.9%+0.6%
Q1 2020+0.5%+3.9%-1.3%
Q4 2019+4.5%+4.1%+15.5%
Q3 2019-10.1%-14.2%-7.4%
Q2 2019+10.5%+9.0%+22.9%
Q1 2019+9.8%+9.2%+10.7%
Q4 2018-6.9%-3.1%+4.9%
Q3 2018+3.2%+5.7%+5.7%
Q2 2018-2.4%-5.9%-1.0%
Q1 2018-4.4%-7.0%-15.6%
Q4 2017+1.4%+1.6%-1.1%
Q3 2017+0.5%+2.0%-4.6%
Q2 2017+0.7%+3.8%+21.6%
Q1 2017+2.4%+4.0%+4.3%
Q4 2016+10.5%+12.2%+11.3%
Q3 2016+0.3%
Q2 2016+1.1%
Q1 2016+0.3%
Q4 2015+2.2%
Q3 2015-2.4%
Q2 2015+2.5%
Q1 2015-2.0%
Q4 2014-1.8%
Q3 2014-2.0%
Q2 2014-5.5%
Q1 2014-6.6%
Q4 2013-1.8%
Q3 2013+0.3%
Q2 2013+0.8%
Q1 2013+1.9%
Q4 2010-3.1%
Q4 2012-3.1%
Q3 2011+3.2%
Q3 2012+3.2%
Q2 2012+2.5%
Q1 2012-3.3%
Q1 2011-3.3%
Q2 2011-3.3%
Q4 2011-3.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro